Preclinical atherosclerosis and cardiovascular events: Do we have a consensus about the role of preclinical atherosclerosis in the prediction of cardiovascular events?-Reference-Cited by-同舟云学术

Preclinical atherosclerosis and cardiovascular events: Do we have a consensus about the role of preclinical atherosclerosis in the prediction of cardiovascular events?

Published:2022-05 Issue: Volume:348 Page:25-35
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Poredoš Pavel,Cífková Renata,Maier Jeanette Anne Marie,Nemcsik Janos,Šabovič Mišo,Jug Borut,Ježovnik Mateja Kaja,Schernthaner Gerit Holger,Antignani Pier Luigi,Catalano Mariella,Fras Zlatko,Höbaus Clemens,Nicolaides Andrew N.,Paraskevas Kosmas I.,Reiner Željko,Wohlfahrt Peter,Poredoš Peter,Blinc Aleš

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference131 articles.

1. Markers of preclinical atherosclerosis and their clinical relevance;Poredoš;Vasa,2015

2. Role of preclinical cardiovascular disease in the evolution from risk factor exposure to development of morbid events;Devereux;Circulation,1993

3. Risk stratification in cardiovascular disease primary prevention - scoring systems, novel markers, and imaging techniques;Zannad;Fundam. Clin. Pharmacol.,2012

4. Sensitivity and specificity of the ankle-brachial index to predict future cardiovascular outcomes: a systematic review;Doobay;Arterioscler. Thromb. Vasc. Biol.,2005

5. Ankle systolic pressure measurements in arterial disease affecting the lower extremities;Yao;Br. J. Surg.,1969

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peripheral artery disease and risk of kidney outcomes: The Atherosclerosis Risk in Communities (ARIC) study;Atherosclerosis;2024-10

2. N6-methyladenosine demethylase fat mass and obesity-associated protein suppresses hyperglycemia-induced endothelial cell injury by inhibiting reactive oxygen species formation via autophagy promotion;Journal of Diabetes and its Complications;2024-08

3. Nanomedicine-based drug delivery strategies for the treatment of atherosclerosis;Medicine in Drug Discovery;2024-06

4. Estándares de la Sociedad Española de Arteriosclerosis 2024 para el control global del riesgo vascular;Clínica e Investigación en Arteriosclerosis;2024-05

5. SEA 2024 Standards for Global Control of Vascular Risk;Clínica e Investigación en Arteriosclerosis (English Edition);2024-05